The mosaic of B-cell subsets (with special emphasis on primary Sjögren's syndrome).
Major breakthroughs have occurred with classification of B-cells into populations and subpopulations. With respect to their expression of CD5, they comprise the B1 and B2 populations, with the former further divided into B1a and B1b subpopulations. The oncologic process starts from transitional type 1 (T1) and T2 immature B-cells, through marginal zone or germinal center B-cells, ending up with memory B-cells and plasma cells (PCs). They may also be categorized based on their functional commitment with polarized B effector (Be)1 and Be2, with B-activating factor of the tumor-necrosis factor-producing B-cells, and with short-lived and long-lived PCs. Such a seemingly homogeneous family of cells has thus turned out to be a genuine mosaic of B-lymphocyte subsets.
Le Pottier
Laetitia
L
Brest University Medical School, Brest, France.
Devauchelle
Valérie
V
Pers
Jacques-Olivier
JO
Jamin
Christophe
C
Youinou
Pierre
P
D016175:B-Lymphocyte Subsets / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D018956:CD5 Antigens / Q000276:immunology; D018858:Germinal Center / Q000276:immunology / Q000473:pathology; D006801:Humans; D007156:Immunologic Memory; D018448:Models, Immunological; D010950:Plasma Cells / Q000276:immunology; D012859:Sjogren's Syndrome / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*
D018956:CD5 Antigens